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Abstract The objective of this study was to establish a he-
patic lipase (HL) assay method that can be applied to auto-
matic clinical analyzers. Seventy-four hyperlipidemic subjects
(men/women 45/29) were recruited. Lipase activity was
assayed measuring the increase in absorbance at 546 nm due
to quinonediimine dye production. Reaction mixture R-1
contained 50 mM Tris-HCl (pH 9.5), 0.5 mM glycerol-1,2-
dioleate, 0.4% (unless otherwise noted) polyoxyethylene-
nonylphenylether, 3 mM ATP, 3 mM MgCl2, 1.5 mM CaCl2,
monoacylglycerol-specific lipase, glycerol kinase, glycerol-
3-phosphate oxidase, 0.075% N,N-bis-(4-sulfobutyl)-3-
methylaniline-2 Na, peroxidase, ascorbic acid oxidase.
Reaction mixture R-2 contained 50 mM Tris-HCl (pH9.5),
0.15% 4-aminoantypirine. Automated assay for activity was
performed with a Model 7080 Hitachi analyzer. In the lipase
assay, 160 ml of R-1 was incubated at 37jC with 3 ml of
samples for 5 min, and 80 ml of R-2 was added. Within-run
coefficient of variations was 0.9–1.0%. Calibration curve of
lipase activity was linear (r 5 0.999) between 0 and 320 U/l.
Analytical recoveries of purified HL added to plasma were
96.6–99.8%. HL activity in postheparin plasma measured in
this method had a closer correlation with HL mass by a
sandwich ELISA (r 5 0.888, P , 0.0001) than those in the
conventional method using [14C-]triolein (r 5 0.730, P ,
0.0001). This assay method for HL activity can be applied
to an automatic clinical analyzer.—Imamura, S., J. Kobayashi,
S. Sakasegawa, A. Nohara, K. Nakajima, M. Kawashiri, A.
Inazu, M. Yamagishi, J. Koizumi, and H. Mabuchi. A novel
method for measuring human hepatic lipase activity in
postheparin plasma. J. Lipid Res. 2007. 48: 453–457.
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Hepatic lipase (HL), a lipolytic enzyme that is a secreted
glycoprotein, is synthesized by hepatocytes and bound to
heparin sulfate proteoglycans at the surface of liver sinu-
soidal capillaries. HL plays a major role in lipoprotein
metabolism as a lipolytic enzyme that hydrolyzes triglycer-
ides (TGs) and phospholipids in chylomicron remnants,
intermediate-density lipoproteins (IDLs), and high-density
lipoproteins (HDLs). Patients with HL deficiency present
with hypercholesterolemia or hypertriglyceridemia and ac-
cumulate b-very-low-density lipoproteins (VLDLs), chylo-
micron remnants, IDLs, TG-rich low-density lipoproteins
(LDLs), and HDLs (1–7).
To date, the only available methods for measuring HL
activity in postheparin plasma (PHP) have used 3H- or 14C-
labeled trioleoyl glycerol as substrates in the presence of
1MNaCl, because lipoprotein lipase (LPL) activity is known
to be completely inhibited and remaining activities are con-
sidered to correspond to HL activity under these condi-
tions. This assay procedure is complicated and does not
appear to be suitable for routine work (8, 9). Several years
ago, a method for measuring HL protein mass by ELISA in
PHP was developed (10).
Still, to diagnose HL deficiency, demonstrating the lack
of HL activity is considered to be essential. In the present
study, therefore, we have developed and established, using
dioleoylglycerol as a substrate, a novel and simple assay sys-
tem for measuring HL activity in PHP that can be applied
to an automatic clinical analyzer.
MATERIALS AND METHODS
Subjects
Seventy-four hyperlipidemic subjects (men/women 45/29)
were recruited for this study (Table 1). The statement of institu-
tional approval of the study was in accordance with the Declara-
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tion of Helsinki, and informed consent was obtained from all
participants. Exclusion criteria included: age .75 years, body
mass index (BMI) .30 kg/m2, diabetes mellitus, abnormal liver
or muscle enzymes, creatinemia, use of antioxidants and lipid
regulators, habitual alcohol intake .3 standard drinks/day, or
endocrinological disorder. Blood samples were obtained follow-
ing a fast of $12 h. PHP was obtained 10 min after 30 U/kg
heparin injection. The monoclonal anti-LPL antibody 5D2 (MAb
5D2) was kindly provided by Dr. John Brunzell of the University
of Washington, Seattle.
Method for measuring lipase activity in partially purified
HL and LPL fractions
HL and LPL were prepared from PHP using heparin-Sepharose
column chromatography (11). HL and LPL were eluted with
0.8 M NaCl and 1.6 M NaCl, respectively. Lipase activity was as-
sayed measuring the increase in absorbance at 546 nm (subwave
length; 660 nm) due to the production of quinonediimine dye
based on the previously described assay procedure (12, 13). Re-
action mixture R-1 contained 50 mM Tris-HCl (pH 9.5), 0.5 mM
dioleoylglycerol, 0.4% polyoxyethylene-nonylphenylether, 3 mM
ATP, 3mMMgCl2, 1.5mMCaCl2, monoacylglycerol-specific lipase
(0.75 U/ml), glycerol kinase (0.75 U/ml), glycerol-3-phosphate
oxidase (37.5 U/ml), 0.075%N,N-bis-(4-sulfobutyl)-3-methylaniline-2
Na, peroxidase (10 U/ml), and ascorbic acid oxidase (10 U/ml).
Reaction mixture R-2 contained 50 mM Tris-HCl (pH 9.5), and
0.15% 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one. Auto-
mated assay of lipase activity was performed with a Model 7080
Hitachi automatic clinical analyzer. In the lipase assay, 160 ml
of R-1 was incubated at 37jC with 3 ml of samples for 5 min, and
then 80 ml of R-2 was added. This reaction produced a violet
quinonediimine dye with a peak absorbance at 546 nm. HL ac-
tivity generating 1 mmol of monoglyceride from diglyceride per
minute was defined as 1 unit.
The method for measuring HL activity in PHP
We measured HL activity in PHP using the above-mentioned
method either in the presence (HL activity) or absence (total li-
pase activity) of 1 M NaCl.
Separation of HL and LPL by heparin-Sepharose CL-6B
PHP (5 ml) was dialyzed against 1 l of 1.6 M NaCl containing
10 mM PIPES-NaOH (pH 7.5) at 4jC for 18 h. The dialysate was
dialyzed against 500 ml of 0.3 M NaCl containing 10 mM PIPES-
NaOH (pH 7.5) at 4jC for 18 h.
The dialysate was applied to a heparin-Sepharose CL-6B col-
umn (1.6 3 3 cm). The column was washed with 30 ml of 0.3 M
NaCl containing 0.1 mM EDTA, 10% sucrose, 0.025% BSA, and
10 mM PIPES-NaOH (pH 7.5).
HL and LPL were eluted with 20 ml of 0.8 M NaCl containing
0.1 mM EDTA, 10% sucrose, 0.025% BSA, 10 mM PIPES-NaOH
(pH 7.5), 20 ml of 1.6 M NaCl containing 0.1 mM EDTA, 10%
sucrose, 0.025% BSA, and 10 mM PIPES-NaOH (pH 7.5) respec-
tively. These HL and LPL fractions were concentrated with an
Amicon Ultra membrane (molecular cut; 30 kDa), reconstituted
with 2 ml of 10 mM PIPES-NaOH (pH 7.5) containing 10% su-
crose and 0.1 mM EDTA. The concentrated HL and LPL was
stored at 220jC.
Effects of MAb 5D2 on lipase activity in PHP- or
NaCl-eluted fraction from heparin-Sepharose
To evaluate the specificities of the lipase activity determined
by the present method, we investigated the effects of the addi-
tion of MAb 5D2 in the reaction mixture against the enzyme
activity in either a PHP- or an 0.8 M NaCl-eluted fraction from
heparin-Sepharose.
The conventional method for measuring HL activity
in PHP
In the conventional method for measuring HL activity in PHP,
total lipase activity was measured using Triton X-100-emulsified
[14C]triolein, based on the previously reported method (8, 9).
The remaining activity in the presence of 1 MNaCl was defined as
HL activity.
The method for measuring HL protein mass in PHP
HL protein mass in PHP was detected using a sandwich ELISA
following the previously described method (10).
Statistical analysis
Statistical evaluation was performed using StatView-J 5.0 soft-
ware (SAS Institute, Cary NC, on a Macintosh Computer). Pearson’s
correlation coefficients analysis was carried out. Results were ex-
pressed as mean 6 SD, and the significance levels were set at
P , 0.05.
RESULTS
Effect on lipase activity of addition of
polyoxyethylene-nonylphenylether in the reaction mixture
Lipase activity detected in our method increased in a
dose-dependent manner with increasing concentrations of
polyoxyethylene-nonylphenylether, a nonionic detergent,
in the reaction mixture (Fig. 1). Lipase activity detected
the fractions eluted in 0.3 M, 0.8 M, and 1.6 M NaCl using
reaction mixtures containing 0.5 mM dioleoylglycerol
(Table 2). Lipase activity was detected only in the fractions
of heparin-Sepharose chromatography eluted in 0.8 M
NaCl, suggesting that this activity corresponds to HL. In
TABLE 1. Clinical profile of the study subjects
Total (n 5 74) Men (n 5 45) Women (n 5 29)
Age, years 53 6 16 52 6 16 54 6 16
BMI, kg/m2 23 6 3 23 6 2 22 6 4
Total cholesterol, mg/dl 259 6 92 246 6 90 278 6 95
TGs, mg/dl 137 6 87 146 6 66 105 6 40
HDL-C, mg/dl 51 6 17 47 6 19 60 6 12
Fasting plasma glucose, mg/dl 96 6 8.3 (n 5 64) 96 6 7.4 (n 5 40) 102 6 34 (n 5 24)
HbA1c, % 5.1 6 0.5 (n 5 53) 5.1 6 0.5 (n 5 32) 5.4 6 1.1 (n 5 21)
BMI, body mass index; HDL, high-density lipoprotein, TG, triglyceride.
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contrast, the LPL fraction (1.6MNaCl) of heparin-Sepharose
chromatography showed no lipase activity, even when apo-
lipoprotein C-II (apoC-II) was added as LPL-specific activator.
Effect of MAb 5D2 on lipase activity in the PHP- or
NaCl-eluted fraction
To determine whether the activity measured in the
present method is affected by anti-LPL MAb, we studied
the additive effect of the MAb 5D2 on lipase activity in
the PHP- or 0.8 M NaCl-eluted fraction from heparin-
Sepharose (Fig. 2). MAb 5D2 did not affect lipase activity
at all in either in the PHP- or the 0.8 M NaCl-eluted frac-
tion, whereas lipase activity in PHP was inhibited by 40% in
the presence of the MAb 5D2 in an assay system for LPL
activity (data not shown).
Correlation of HL activity with HL mass in PHP
HL activity in PHP measured in the present method was
highly correlated with HL mass by a sandwich ELISA in
74 hyperlipidemic Japanese subjects (Fig. 3). By compari-
son, HL activity measured in the conventional method
using Triton X-100-emulsified [14C]triolein as a substrate
[conventional HL (cHL) activity] had a weaker correlation
with HL mass.
We also analyzed the correlation of HL activity with HL
mass in PHP in men (n 5 45). HL activity in PHP mea-
sured in the present method was highly correlated with
HL mass by a sandwich ELISA (r 5 0.886, P , 0.001). By
comparison, cHL activity had a weaker correlation with HL
mass (r 5 0.676, P , 0.001).
Furthermore, we analyzed correlation of HL activity
with HL mass in PHP in women (n 5 29). HL activity
in PHP measured in the present method was highly cor-
related with HL mass by a sandwich ELISA (r 5 0.901,
P , 0.001). By comparison, cHL activity had a slightly
weaker correlation with HL mass (r 5 0.852, P , 0.001).
HL activity in PHP measured in the presence or absence
of NaCl
The remaining activity in the presence of 1 M NaCl
using Triton X-100-emulsified [14C]triolein as a substrate
is usually interpreted as HL activity. Unexpectedly, the cor-
relation coefficient of HL activity in the absence of 1 M
NaCl with HL mass was almost equal to that in the pres-
ence of 1 M NaCl with HL mass (0.892 vs. 0.901 in women;
0.895 vs. 0.886 in men) (Table 3).
Correlation of HL activity with age and BMI
HL activity did not show a significant correlation with
age or BMI in the study subjects (Table 3). Even measured
separately for each gender, no correlation existed (data
not shown).
Correlation of HL activity with lipids and lipoproteins
HL activity in the present method did not have signifi-
cant associations with total cholesterol or TG, and had
TABLE 2. Lipase activity in the fractions eluted in 0.3 M, 0.8 M, and
1.6 M NaCl using dioleoylglycerol as substrate
Fractions Activity (U/l) Total Activity (mU)
Plasma 252 1,260
0.3 M NaCl 0 0
0.8 M NaCl eluate 38 760
0.8 M NaCl concentrate 320 640
1.6 M NaCl concentrate 0 0
Fig. 2. Effect of anti-lipoprotein lipase monoclonal antibody 5D2
on lipase activity in postheparin plasma (PHP)- or 0.8 NaCl-eluted
fraction from heparin-Sepharose. The reaction condition for the
measurement of lipase activity was described inMaterials andMeth-
ods, with the exception that increasing amounts of 5D2 were added
in the reaction mixture. PHP was obtained from a normal volun-
teer 10 min after 30 U/kg heparin injection.
Fig. 1. Effect of increasing concentrations of polyoxyethylene-
nonylphenylether on lipase activity in the reaction mixture for HL
activity assay. Methods were described in detail in the Materials and
Methods section, except that the effect of various concentrations
of polyoxyethylene-nonylphenylether on HL activity in the reac-
tion mixture was investigated in this particular experiment. The
horizontal line shows the final concentration of polyoxyethylene-
nonylphenylether in the reaction mixture.
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an inverse association with HDL-C and HDL2-C (Table 3).
Measured separately for each gender, the observed asso-
ciations between HL activity and HDL-C did not reach
statistical significance, partly because of the small sample
size (data not shown).
Other findings
The within-run (n 5 20) coefficient of variation was
0.9–1.0%. The calibration curve of lipase activity was linear
(r5 0.999) between 0 and 500 U/l. Analytical recoveries of
purified HL added to plasma were 96.6–99.8%. This
method was free of interference by bilirubin C, bilirubin F,
ascorbic acid, and intra-lipid. Weak interference by hemo-
globin was observed. High activity of human pancreatic
lipase (1,000 U/l) showed no lipase activity.
DISCUSSION
In the present study, we have developed a novel method
for measuring HL activity in PHP. Instead of radioisotope-
labeled substrate, we have used 0.2 mM dioleoylglycerol as
a substrate for this new lipase assay.
The finding shown in Fig. 1 suggests that the existence
of polyoxyethylene-nonylphenylether, a nonionic detergent,
in the reaction mixture appeared to be a critical factor
in the expression of HL enzyme activity, although at this
time, the precise mechanisms have not been elucidated.
Glycerol-1,2-dioleate became clear by adding nonionic de-
tergent, suggesting that glycerol-1,2-dioleate came to exist
in the reaction mixture as water-soluble mixed micelles
with this nonionic detergent.
The result shown in Table 2 that lipase activity was
detected only in the 0.8 M NaCl-eluted fraction of the
heparin-Sepharose indicated that lipase activity detected
in the present method corresponds to that of HL. Also, the
finding that the MAb 5D2 did not affect lipase activity in
the 0.8 M NaCl-eluted fraction and PHP confirmed that
this method specifically detected HL activity (Fig. 2). HL
activity obtained using this method showed stronger associ-
ations with HL mass by sandwich ELISA than did cHL ac-
tivity measured using Triton X-100-emulsified [14C]triolein
(8, 9). This suggests that the present method could be
more reliable for measuring HL activity in PHP than
the conventional method using Triton X-100-emulsified
[14C]triolein as a substrate.
A previous report has shown extremely high correlation
between HL mass and activity in PHP (10). However, their
method for measuring HL activity requires 3H-labeled tri-
olein and is labor intensive and time consuming. HL is
a lipolytic enzyme catalyzing the hydrolysis of TG and PL
in IDL and HDL2. Whether HL is atherogenic or anti-
atherogenic is still the subject of debate (14–17). Because
HL lowers plasma concentrations of the pro-atherogenic
apoB-containing lipoproteins as well as the anti-atherogenic
HDL, the net effect of these HL-induced alterations in
plasma lipoproteins on coronary artery disease is not easily
predictable. Patients with HL deficiency present with hy-
percholesterolemia or hypertriglyceridemia and accumu-
late b-VLDLs, chylomicron remnants, IDLs, TG-rich LDLs,
and HDLs (1–7). The clinical profile of this lipid disorder
could be quite similar to that of type III hyperlipidemia,
TABLE 3. Correlation of HL activity and mass with several metabolic
parameters in men and women combined (N 5 74)
T-Lipase Activity HL Activity HL Mass cHL Activity
BMI 20.035 20.059 0.024 20.057
Total cholesterol 20.075 20.042 20.047 0.240a
TGs 0.144 0.167 0.290a 0.119
HDL-C 20.330b 20.310b 20.356b 20.183
HDL2-C 20.317
b 20.300a 20.348b 20.231
HDL3-C 20.070 20.051 20.031 0.159
T-lipase activity na 0.978c 0.896c 0.743c
HL activity 0.978c na 0.888c 0.747c
HL mass 0.896c 0.888c na 0.730c
cHL activity 0743c 0.747c 0.730c na
T-lipase, total lipase; HL, hepatic lipase; na, not available; cHL
activity, HL activity measured in conventional method using Triton X-
100-emulsified [14C]triolein.
Lipase activities measured in the absence and the presence of 1 M
NaCl were referred to as T-lipase activity and HL activity, respectively.
a P , 0.05.
b P , 0.01.
c P , 0.001.
Fig. 3. Relationship of HL mass to HL activity and total lipase
activity from PHP in 74 hyperlipidemic Japanese subjects (men/
women 45/29). Lipase activity in PHP was measured using the
method described in Materials and Methods in either the presence
(HL activity) or absence (total lipase activity) of 1 M NaCl. HL
activity generating 1 mmol of monoglyceride from diglyceride per
minute was defined as 1 unit. HL mass is shown in ng/ml.
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which makes it difficult to identify this lipid disorder. To
identify patients with HL deficiency, it is essential to dem-
onstrate the lack of HL activity in PHP. In contrast, LPL
deficiency is relatively easily identified, because patients
with this lipid disorder usually have drastic hyperlipid-
emia due to marked accumulation of chylomicrons in the
serum, causing acute pancreatitis (7). To date, as men-
tioned above, the available method for measuring HL ac-
tivity in PHP has used 3H- or 14C-labeled trioleoyl glycerol
as substrates in the presence of 1 M NaCl (8, 9). However,
these assay procedures are complicated and require the
use of radioisotopes. In the present study, therefore, we
have developed and established a novel assay system for
measuring HL activity in PHP using dioleoylglycerol as a
substrate, without requiring radioisotope labeling. The re-
sults presented in Table 3, showing that total lipase activity
(measured in the absence of 1 M NaCl) was similar to HL
activity (measured in the presence of 1 MNaCl) in terms of
correlation coefficients with HL mass, suggested that this
assay could be suitable for measuring HL activity in the
presence or absence 1 M NaCl.
With regard to the correlation of HL activity with lipid
and lipoproteins, there were inverse correlations with
HDL-C (HDL2-C) in the whole subjects, but there was no
correlation with BMI, total cholesterol, TGs, or HDL3-C.
These findings might be compatible with the fact that HL
is involved in catalyzing hydrolysis of TG in HDL2-C (7, 18).
In addition to LPL and HL, in the past decade, consid-
erable attention has been paid to the physiological role of
endothelial lipase (EL) (19), which is known to have higher
phospholipase activity and lower activity in TG hydrolysis,
comparedwith the other two lipases (20). To our knowledge,
however, there has been no report on what proportion of
lipase activity in PHP is accounted for by EL. Despite this,
we presume that there is little or no possibility that our
present method for measuring HL activity overlapped the
activity of EL, in view of their high positive correlation to
HL mass.
In summary, we have developed a novel and simple
method for the assay of HL activity in PHP, which is suit-
able for application to an automatic clinical analyzer.
REFERENCES
1. Jansen, H., A. J. Verhoeven, L. Weeks, J. J. Kastelein, D. J. Halley,
A. van den Ouweland, J. W. Jukema, J. C. Seidell, and J. C.
Birkenhaer. 1997. Common C-to-T substitution at position -480 of
the hepatic lipase promoter associated with a lowered lipase ac-
tivity in coronary artery disease patients. Arterioscler. Thromb. Vasc.
Biol. 17: 2837–2842.
2. Breckenridge, W. C., J. A. Little, P. Alaupovic, C. S. Wang, A. Kuksis,
G. Kakis, F. Lindgren, and G. Gardiner. 1982. Lipoprotein ab-
normalities associated with a familial deficiency of hepatic lipase.
Atherosclerosis. 45: 161–179.
3. Hegele, R. A., J. A. Little, C. Vezina, G. F. Maguire, L. Tu, T. S.
Wolever, D. J. A. Jenkins, and P. W. Connelly. 1993. Hepatic lipase
deficiency. Clinical, biochemical, and molecular genetic character-
istics. Arterioscler. Thromb. 13: 720–728.
4. Carlson, L. A., L. Holmquist, and P. Nilsson-Ehle. 1986. Deficiency
of hepatic lipase activity in post-heparin plasma in familial hyper-
[alpha]-triglyceridemia. Acta Med. Scand. 219: 435–447.
5. Brand, K., K. A. Dugi, J. D. Brunzell, D. N. Nevin, H. B. Brewer, Jr.,
and S. Santamarina-Fojo. 1996. A novel AYG mutation in intron I
of the hepatic lipase gene leads to alternative splicing resulting in
enzyme deficiency. J. Lipid Res. 37: 1213–1223.
6. Knudsen, P., M. Antikainen, S. Ehnholm, M. Uusi-Oukari, H.
Tenkanen, S. Kahri, J. Lahdenpera, M. Tilly-Kiesi, A. Bensadoun,
M. R. Taskinen, et al. 1996. A compound heterozygote for hepatic
lipase gene mutations Leu334YPhe and Thr383YMet: correla-
tion between hepatic lipase activity and phenotypic expression.
J. Lipid Res. 37: 825–834.
7. Brunzell, J. D., and S. S. Deeb. 2001. Familial lipoprotein lipase
deficiency, apoC-II deficiency, and hepatic lipase deficiency. In The
Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver,
A. L. Beaudet, W. S. Sly, et al., editors. McGraw-Hill, New York.
2789–2816.
8. Kobayashi, J., T. Nishida, D. Ameis, G. Stahnke, M. C. Schotz, H.
Hashimoto, I. Fukamachi, K. Shirai, Y. Saito, and S. Yoshida. 1992.
A heterozygous mutation (the codon for Ser447— -a stop codon)
in lipoprotein lipase contributes to a defect in lipid interface rec-
ognition in a case with type I hyperlipidemia. Biochem. Biophys. Res.
Commun. 182: 70–77.
9. Kobayashi, J., K. Shirai, Y. Saito, and S. Yoshida. 1989. Lipoprotein
lipase with a defect in lipid interface recognition in a case with
type I hyperlipidaemia. Eur. J. Clin. Invest. 19: 424–432.
10. Nishimura, M., Y. Ohkaru, H. Ishii, N. Sunahara, A. Takagi, and
Y. Ikeda. 2000. Development and evaluation of a direct sandwich-
enzyme-linked immunosorbent assay for the quantification of hu-
man hepatic triglyceride lipase mass in human plasma. J. Immunol.
Methods. 235: 41–51.
11. Ikeda, Y., A. Takagi, and A. Yamamoto. 1989. Purification and char-
acterization of lipoprotein lipase and hepatic triglyceride lipase
from human postheparin plasma: production of monospecific anti-
body to the individual lipase. Biochim. Biophys. Acta. 1003: 254–269.
12. Fossati, P., M. Ponti, P. Paris, G. Berti, and G. Tarenghi. 1992. Ki-
netic colorimetric assay of lipase in serum. Clin. Chem. 38: 211–215.
13. Panteghini, M., F. Pagani, and R. Bonara. 1993. Clinical and ana-
lytical evaluation of a continuous enzymatic method for measuring
pancreatic lipase activity. Clin. Chem. 39: 304–308.
14. Jansen, H., A. J. Verhoeven, and E. J. Sijbrands. 2002. Hepatic li-
pase: a pro- or anti-atherogenic protein? J. Lipid Res. 43: 1352–1362.
15. Jansen, H. 2004. Hepatic lipase: friend or foe and under what
circumstances? Curr. Atheroscler. Rep. 6: 343–347.
16. Zambon, A., S. S. Deeb, P. Pauletto, G. Crepaldi, and J. D. Brunzell.
2003. Hepatic lipase: a marker for cardiovascular disease risk and
response to therapy. Curr. Opin. Lipidol. 14: 179–189.
17. Santamarina-Fojo, S., C. Haudenschild, and M. Amar. 1998. The
role of hepatic lipase in lipoprotein metabolism and atherosclerosis.
Curr. Opin. Lipidol. 9: 211–219.
18. Shirai, K., R. L. Barnhart, and R. L. Jackson. 1981. Hydrolysis of
human plasma high density lipoprotein 2- phospholipids and triglyc-
erides by hepatic lipase. Biochem. Biophys. Res. Commun. 100: 591–599.
19. Jaye, M., K. J. Lynch, J. Krawiec, D. Marchadier, C. Maugeais, K.
Doan, V. South, D. Amin, M. Perrone, and D. J. Rader. 1999. A
novel endothelial-derived lipase that modulates HDL metabolism.
Nat. Genet. 21: 424–428.
20. McCoy, M. G., G. S. Sun, D. Marchadier, C. Maugeais, J. M. Glick,
and D. J. Rader. 2002. Characterization of the lipolytic activity of
endothelial lipase. J. Lipid Res. 43: 921–929.
A novel assay method for hepatic lipase activity 457
 at KAN
AZAW
A UNIVERSITY, on February 25, 2018
w
w
w
.jlr.org
D
ow
nloaded from
 
